Cargando…

Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT

The nephrotoxicity of Fructus Psoraleae, an effective traditional Chinese medicine for vitiligo treatment, has been reported. As one of the main toxic components in Fructus Psoraleae, bavachin (BV) was considered to be related to Fructus Psoraleae-caused adverse outcomes, but the direct evidence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Yu-Hao, Deng, Hui-Fang, Zhou, Lei, Huang, Cong-Shu, Wang, Ning-Ning, Yue, Lan-Xin, Li, Gao-Fu, Yu, Hui-Jing, Zhou, Wei, Gao, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304982/
https://www.ncbi.nlm.nih.gov/pubmed/35873571
http://dx.doi.org/10.3389/fphar.2022.872474
_version_ 1784752213573238784
author Ni, Yu-Hao
Deng, Hui-Fang
Zhou, Lei
Huang, Cong-Shu
Wang, Ning-Ning
Yue, Lan-Xin
Li, Gao-Fu
Yu, Hui-Jing
Zhou, Wei
Gao, Yue
author_facet Ni, Yu-Hao
Deng, Hui-Fang
Zhou, Lei
Huang, Cong-Shu
Wang, Ning-Ning
Yue, Lan-Xin
Li, Gao-Fu
Yu, Hui-Jing
Zhou, Wei
Gao, Yue
author_sort Ni, Yu-Hao
collection PubMed
description The nephrotoxicity of Fructus Psoraleae, an effective traditional Chinese medicine for vitiligo treatment, has been reported. As one of the main toxic components in Fructus Psoraleae, bavachin (BV) was considered to be related to Fructus Psoraleae-caused adverse outcomes, but the direct evidence and molecular mechanism underlying BV-induced nephrotoxicity are not well elucidated. Therefore, this study was designed to confirm whether BV would cause toxic effects on the kidney and explore the possible mode of action. Our results demonstrated that days’ treatment with 0.5 μM BV indeed caused obvious renal fibrosis in the zebrafish kidney. The obvious E- to N-cadherin switch and the expressions of proteins promoting epithelial–mesenchymal transition (EMT) were observed in BV-treated human renal tubular epithelial and zebrafish kidneys. In addition, elevated reactive oxygen species (ROS) levels and Bip/eIF2α/CHOP-mediated endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) were caused by BV, both of which could be reversed by ROS scavenger N-acetyl-L-cysteine (NAC). Also, blocking ER stress-caused cytoplasmic Ca(2+) overload with 4-PBA notably alleviated BV-induced alterations in key molecular events related to EMT and renal fibrosis. Furthermore, of the natural compounds subjected to screening, ginsenoside Rb1 significantly downregulated BV-induced ER stress by inhibiting ROS generation and following the activation of Bip/eIF2α/CHOP signaling in HK2 cells. Subsequently, BV-triggered EMT and renal fibrosis were both ameliorated by ginsenoside Rb1. In summary, our findings suggested that BV-induced ROS promoted the appearance of EMT and renal fibrosis mainly via Bip/eIF2α/CHOP-mediated ER stress. This ER stress-related toxic pathway might be a potential intervention target for BV-caused renal fibrosis, and ginsenoside Rb1 would be a promising drug against BV- or Fructus Psoraleae-induced nephrotoxicity.
format Online
Article
Text
id pubmed-9304982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93049822022-07-23 Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT Ni, Yu-Hao Deng, Hui-Fang Zhou, Lei Huang, Cong-Shu Wang, Ning-Ning Yue, Lan-Xin Li, Gao-Fu Yu, Hui-Jing Zhou, Wei Gao, Yue Front Pharmacol Pharmacology The nephrotoxicity of Fructus Psoraleae, an effective traditional Chinese medicine for vitiligo treatment, has been reported. As one of the main toxic components in Fructus Psoraleae, bavachin (BV) was considered to be related to Fructus Psoraleae-caused adverse outcomes, but the direct evidence and molecular mechanism underlying BV-induced nephrotoxicity are not well elucidated. Therefore, this study was designed to confirm whether BV would cause toxic effects on the kidney and explore the possible mode of action. Our results demonstrated that days’ treatment with 0.5 μM BV indeed caused obvious renal fibrosis in the zebrafish kidney. The obvious E- to N-cadherin switch and the expressions of proteins promoting epithelial–mesenchymal transition (EMT) were observed in BV-treated human renal tubular epithelial and zebrafish kidneys. In addition, elevated reactive oxygen species (ROS) levels and Bip/eIF2α/CHOP-mediated endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) were caused by BV, both of which could be reversed by ROS scavenger N-acetyl-L-cysteine (NAC). Also, blocking ER stress-caused cytoplasmic Ca(2+) overload with 4-PBA notably alleviated BV-induced alterations in key molecular events related to EMT and renal fibrosis. Furthermore, of the natural compounds subjected to screening, ginsenoside Rb1 significantly downregulated BV-induced ER stress by inhibiting ROS generation and following the activation of Bip/eIF2α/CHOP signaling in HK2 cells. Subsequently, BV-triggered EMT and renal fibrosis were both ameliorated by ginsenoside Rb1. In summary, our findings suggested that BV-induced ROS promoted the appearance of EMT and renal fibrosis mainly via Bip/eIF2α/CHOP-mediated ER stress. This ER stress-related toxic pathway might be a potential intervention target for BV-caused renal fibrosis, and ginsenoside Rb1 would be a promising drug against BV- or Fructus Psoraleae-induced nephrotoxicity. Frontiers Media S.A. 2022-07-08 /pmc/articles/PMC9304982/ /pubmed/35873571 http://dx.doi.org/10.3389/fphar.2022.872474 Text en Copyright © 2022 Ni, Deng, Zhou, Huang, Wang, Yue, Li, Yu, Zhou and Gao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ni, Yu-Hao
Deng, Hui-Fang
Zhou, Lei
Huang, Cong-Shu
Wang, Ning-Ning
Yue, Lan-Xin
Li, Gao-Fu
Yu, Hui-Jing
Zhou, Wei
Gao, Yue
Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT
title Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT
title_full Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT
title_fullStr Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT
title_full_unstemmed Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT
title_short Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT
title_sort ginsenoside rb1 ameliorated bavachin-induced renal fibrosis via suppressing bip/eif2α/chop signaling-mediated emt
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304982/
https://www.ncbi.nlm.nih.gov/pubmed/35873571
http://dx.doi.org/10.3389/fphar.2022.872474
work_keys_str_mv AT niyuhao ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT denghuifang ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT zhoulei ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT huangcongshu ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT wangningning ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT yuelanxin ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT ligaofu ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT yuhuijing ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT zhouwei ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt
AT gaoyue ginsenosiderb1amelioratedbavachininducedrenalfibrosisviasuppressingbipeif2achopsignalingmediatedemt